White label – Pompe disease - ClinicalTrials.eu

Study on Gabapentin and Placebo for Short-Term Relief of Acute Lower Back Pain from Herniated Disc in Adults

Not recruiting

3 1 1
Investigated Diseases:
Investigated Drugs:
- Gabapentin
Study on Celecoxib for Reducing Symptoms in Adults with Major Depressive Disorder and Immuno-metabolic Characteristics

Not recruiting

3 1 1
Investigated Drugs:
- Celecoxib
Study on Organ Preservation in Advanced Rectal Cancer Using Oxaliplatin, Fluorouracil, and Calcium Folinate for Patients with Confirmed Rectal Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Rectal cancer
Investigated Drugs:
Study of Bexmarilimab Combined with Standard Treatment for Patients with Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Not recruiting

1 1 1
Investigated Drugs:
- Bexmarilimab
Study on VE202 for Patients with Mild-to-Moderate Ulcerative Colitis

Not recruiting

2 1 1
Investigated Drugs:
Study on the Effectiveness of Tislelizumab and Spartalizumab in Patients with Advanced or Metastatic Cancer with High PD1 Biomarker Levels

Not recruiting

2 1 1 1
Investigated Drugs:
- Spartalizumab
- Tislelizumab
Study on Atezolizumab with Chemoradiotherapy for Patients with Limited Disease Small-Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Small cell lung cancer
Investigated Drugs:
- Atezolizumab
Study on the Effects of Dexamethasone and Olanzapine in Patients Resuscitated from Out-of-Hospital Cardiac Arrest

Not recruiting

3 1 1
Investigated Drugs:
Study of isatuximab and pegenzileukin combination treatment for patients with relapsed or refractory multiple myeloma who previously received anti-CD38 and anti-BCMA therapy

Not recruiting

1 1 1
Investigated Diseases:
- Plasma cell myeloma refractory
Investigated Drugs:
- Pegenzileukin
- Isatuximab
Study of Avapritinib for Patients with Indolent Systemic Mastocytosis Not Adequately Managed by Standard Therapy

Not recruiting

2 1
Investigated Drugs:
- Avapritinib
+3

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies